Kilder

Berende A, ter Hofstede HJ, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M, van den Hoogen FH, Donders AR, Evers A. Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. Randomized Controlled Trial. N Engl J Med. 2016;374(13):1209-20. doi: 10.1056/NEJMoa1505425.

Borchers AT, Keen CL, Huntley AC, Gershwin ME. Lyme disease: A rigorous review of diagnostic criteria and trestment. J Autoimmun. 2015:57:82-115. doi: 10.1016/j.jaut.2014.09.004. 

Dessau RB, Bangsborg J, Hansen K, Lebech AM, Sellebjerg FT, Skarphédinson S, Østergaard C. Lyme Borreliose: Klinik, diagnostik og behandling i Danmark. (2. utgave). 2014. http://dskm.dk/onewebmedia/Borrelia%20klaringsrapport%202.udgave%202014.pdf 

Eikeland R. Nevroborreliose. Norsk Elektronisk Legehåndbok - Nevrologi. Oppdatert 31.10.2022

Eliassen KE, Berild D, Reiso H, Grude N, Christophersen KS, Finckenhagen C, Lindbæk M. Incidence and antibiotic treatment of erythema migrans in Norway 2005-2009. Ticks Tick Borne Dis. 2017;8(1):1-8. doi: 10.1016/j.ttbdis.2016.06.006. 

Hagberg, L. Borrelia. www.internetmedicin.se. 2023.

Haugeberg G, Hansen IJ, Skarpaas T, Noraas S, Kjelland V. Lyme arthritis in Southern Norway--an endemic area for Lyme borreliosis. BMC Infect Dis. 2014;14:185.

Helsedirektoratet. Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Oppdatert 01.03.2024

Helsedirektoratet. Nasjonal faglig retningslinje for bruk av antibiotika i sykehus. Oppdatert 2022.

Knudtzen FC, Andersen NS, Jensen TG, Skarphédinsson W, Kullberg BJ. Characteristics and Clinical Outcome of Lyme Neuroborreliosis in a High Endemic Area, 1995-2014: A Retrospective Cohort Study in Denmark.Clin Infect Dis. 2017;65(9):1489-1495. doi: 10.1093/cid/cix568.

Kristiansen BE, Grude N, Tveten Y, Emmert A. Laboratoriediagnostikk av Lyme-borreliose. Tidsskr Nor Laegeforen. 2009;129(20):2132-4. doi: 10.4045/tidsskr.09.0849. 

Ljøstad, U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg Å, Mygland Å. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7(8):690-695

Stanek G, Fingerle V, Hunfeld K-P, Jaulhac B, Kaiser B, Krause A, Kristoferitsch W, O’Connel S, Ornstein K, Strle F, Gray J. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011; 17(1):69-79. doi: 10.1111/j.1469-0691.2010.03175.x.

Wormser GP, Dattwyler RJ, Shapiro ED et al. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-134. doi: 10.1086/508667

Øymar K, Tveitnes D. Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe. Scand J Infect Dis. 2009;41(2):88-94. doi: 10.1080/00365540802593453.